BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25126810)

  • 21. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study.
    Thatrimontrichai A; Apisarnthanarak A; Chanvitan P; Janjindamai W; Dissaneevate S; Maneenil G
    Pediatr Infect Dis J; 2013 Feb; 32(2):140-5. PubMed ID: 22935872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
    Liu Q; Li W; Du X; Li W; Zhong T; Tang Y; Feng Y; Tao C; Xie Y
    PLoS One; 2015; 10(6):e0130701. PubMed ID: 26083415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. isolates that cause bacteremia and urinary tract infections in Korea.
    Park YK; Lee GH; Baek JY; Chung DR; Peck KR; Song JH; Ko KS
    Microb Drug Resist; 2010 Jun; 16(2):143-9. PubMed ID: 20370437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia.
    Chuang YC; Sheng WH; Li SY; Lin YC; Wang JT; Chen YC; Chang SC
    Clin Infect Dis; 2011 Feb; 52(3):352-60. PubMed ID: 21193494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
    Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
    J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation and control of an outbreak of imipenem-resistant Acinetobacter baumannii Infection in a Pediatric Intensive Care Unit.
    Hong KB; Oh HS; Song JS; Lim JH; Kang DK; Son IS; Park JD; Kim EC; Lee HJ; Choi EH
    Pediatr Infect Dis J; 2012 Jul; 31(7):685-90. PubMed ID: 22466324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multilocus sequence typing and molecular characterization of β-lactamase genes among Acinetobacter baumannii isolates in a burn center.
    Huang G; Peng Y; Yang Y; Tang C; Fu Y
    Burns; 2017 Nov; 43(7):1473-1478. PubMed ID: 28461077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal spread of blaOXA-72-carrying Acinetobacter baumannii sequence type 512 in Taiwan.
    Kuo HY; Hsu PJ; Chen JY; Liao PC; Lu CW; Chen CH; Liou ML
    Int J Antimicrob Agents; 2016 Jul; 48(1):111-113. PubMed ID: 27242318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.
    El Bannah AMS; Nawar NN; Hassan RMM; Salem STB
    Microb Drug Resist; 2018 Apr; 24(3):269-277. PubMed ID: 28783427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: susceptibility and clinical outcome.
    Kim NH; Hwang JH; Song KH; Choe PG; Kim ES; Park SW; Kim HB; Kim NJ; Park WB; Oh MD
    Scand J Infect Dis; 2013 Apr; 45(4):315-9. PubMed ID: 23113680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
    Kopterides P; Koletsi PK; Michalopoulos A; Falagas ME
    Int J Antimicrob Agents; 2007 Nov; 30(5):409-14. PubMed ID: 17851052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei.
    Tojo M; Mawatari M; Hayakawa K; Nagamatsu M; Shimada K; Mezaki K; Sugiki Y; Kuroda E; Takeshita N; Kutsuna S; Fujiya Y; Miyoshi-Akiyama T; Kirikae T; Ohmagari N
    J Infect Chemother; 2015 Mar; 21(3):212-4. PubMed ID: 25444675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological characterization of Acinetobacter baumannii bloodstream isolates from a Chinese Burn Institute: A three-year study.
    Huang G; Yin S; Xiang L; Gong Y; Sun K; Luo X; Zhang C; Yang Z; Deng L; Jiang B; Jin S; Chen J; Peng Y
    Burns; 2016 Nov; 42(7):1542-1547. PubMed ID: 27614427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Description of the OXA-23 β-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain.
    Guerrero-Lozano I; Fernández-Cuenca F; Galán-Sánchez F; Egea P; Rodríguez-Iglesias M; Pascual Á
    Microb Drug Resist; 2015 Apr; 21(2):215-7. PubMed ID: 25386800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the genetic elements bla oxa and IS Aba 1 in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex in carbapenem resistance in the hospital setting.
    Kobs VC; Ferreira JA; Bobrowicz TA; Ferreira LE; Deglmann RC; Westphal GA; França PH
    Rev Soc Bras Med Trop; 2016; 49(4):433-40. PubMed ID: 27598629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence of Acinetobacter baumannii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-β-lactamases in Rabat Military Teaching Hospital Mohammed V].
    Gildas Comlan Zohoun A; Moket D; El Hamzaoui S
    Ann Biol Clin (Paris); 2013; 71(1):27-30. PubMed ID: 23396427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Liu CP; Shih SC; Wang NY; Wu AY; Sun FJ; Chow SF; Chen TL; Yan TR
    J Microbiol Immunol Infect; 2016 Dec; 49(6):934-940. PubMed ID: 25553994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colonization pressure and risk factors for acquisition of imipenem-resistant Acinetobacter baumannii in a medical surgical intensive care unit in Brazil.
    Castelo Branco Fortaleza CM; Moreira de Freitas F; da Paz Lauterbach G
    Am J Infect Control; 2013 Mar; 41(3):263-5. PubMed ID: 22878125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.